A product of human origin is more likely to be safe, and is likely to have some biological effect because why else would to be there? So we agree there to some extent.. But it is a dangerous assumption to place too much stock in that. For example, the cytokines tnf and il2 are produced during immune responses, including against cancer. People assumed that man made versions would therefore be magic bullets ( or at least helpful) in treating humans for cancer and other conditions. Turns out, they can be disastrous when administered and even life threatening. Natural does not equal safe (although nnz 2556) seems to have no probs) or effective.
The argument can also be made that if its already made by humans, then shouldn't that be protective already - wouldn't we just make more ourselves if that was all that was needed. So, yes it is present in humans, but it is not known if it works - at least not in the way neu hopes it will. And if it did - there might no be the need for a treatment.a circular argument I guess to some degree, but important caveats to your argument I think. But all that aside, you're in this for an investment and I suspect you are now well ahead. As an investment from your starting point, it's been a winner already. It was thanks to you that I got in early too (you me, FP and porky it seems) although I sold out before this latest surge ( fortunately, I bought ahz with the proceeds ). I made a small profit on neu, so am grateful for your insights, but forgive me for pointing out instances of over-enthusiasm. You may not agree, but at least I spell out my reasoning so others can judge for themselves.
NEU Price at posting:
6.1¢ Sentiment: Sell Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)